{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-080280","form_type":"8-K","ticker":"PFX","cik":"0001490349","company_name":"PhenixFIN Corp","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.826181+00:00","generated_at":"2026-06-21T03:17:02.660516+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PhenixFIN Q4 2022: NII $1.9M, NAV $57.49/shr, new $50M credit facility","bullets":["Q4 total investment income $5.1M, net investment income $1.9M.","NAV $120.8M ($57.49/shr) vs $57.08/shr a year ago; portfolio fair value $193.0M.","Secured 3-yr $50M credit facility (SOFR+2.90%); will redeem $22.5M 6.125% notes due 2023.","Repurchased 16.5% of shares outstanding in FY2022; weighted avg yield to maturity 10.85%.","Net realized loss $10.3M on sale of Path Medical; net unrealized loss $3.7M from market volatility."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-080280","json":"https://secwatch.observer/filing/0001213900-22-080280.json","markdown":"https://secwatch.observer/filing/0001213900-22-080280.md","text":"https://secwatch.observer/filing/0001213900-22-080280.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1490349/000121390022080280/0001213900-22-080280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1490349/000121390022080280/ea170028-8k_phenixfin.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:17:02.660516+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58dbf73eac0dee28c498b6de70459990ec0bad7f","claim":"PhenixFIN Corp reported fiscal fourth quarter of 2022 results: revenue $5.1 million, net income $1.9 million.","evidence_excerpt":"traded business development company, today announced its financial results for the fiscal fourth quarter of 2022. Highlights ● Fourth quarter total investment income was $5.1 million; net investment income of $1.9 million ● Net asset value (NAV) of $120.8 million, or $57.49 per share as of September 30, 2022, vs. $57.08 per share as of September 30, 2021 ●","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1490349/000121390022080280/0001213900-22-080280-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal fourth quarter of 2022"},{"label":"Revenue","value":"$5.1 million"},{"label":"Net income","value":"$1.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}